Gabapentin
- Product NDC
- 0615-8019
- 11-digit product format
- 006158019
- Labeler code
- 0615
- Product ID
- 0615-8019_fe11b422-811b-4de4-8d2f-2b8961de9b4b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA077662
- Marketing category
- ANDA
- Marketing start
- 2006-04-01
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-8019-05 | 2021-05-06 | C162847 | 48780-1 | 9d75b9d0-8233-f424-e053-dadaa90a57ce | 36e6ee42-a7de-44a8-bc3b-559787a57029 |
| 0615-8019-30 | 2021-05-06 | C162847 | 48780-1 | 9d75b9d0-8233-f424-e053-dadaa90a57ce | 36e6ee42-a7de-44a8-bc3b-559787a57029 |
| 0615-8019-39 | 2021-05-06 | C162847 | 48780-1 | 9d75b9d0-8233-f424-e053-dadaa90a57ce | 36e6ee42-a7de-44a8-bc3b-559787a57029 |
| 0615-8019-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8233-f424-e053-dadaa90a57ce | 36e6ee42-a7de-44a8-bc3b-559787a57029 |
| 0615-8019-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8233-f424-e053-dadaa90a57ce | 36e6ee42-a7de-44a8-bc3b-559787a57029 |
| 0615-8019-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8233-f424-e053-dadaa90a57ce | 36e6ee42-a7de-44a8-bc3b-559787a57029 |